上海谊众大跌7.72% 营收净利双下滑

智选洞察2025-04-23

04月23日，上海谊众（688091）股价大幅下跌，截至09点30分，上海谊众下跌7.72%，报44.01元/股，成交1127万元，换手率0.12%，振幅0.02%。消息解读上海谊众4月22日发布了2024年度财报，尽管其核心产品注射用紫杉醇聚合物胶束成功纳入国家医保目录，但受市场准入困难及研发投入增加等因素影响，公司营收与净利润双双大幅下滑。2024年上海谊众实现营业收入1.74亿元，同比下降...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2529594789?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-23 09:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2529594789","market":"sh","top_or_hot":-1,"title":"上海谊众大跌7.72% 营收净利双下滑","media":"智选洞察","content":"<div>\n<p>04月23日，上海谊众（688091）股价大幅下跌，截至09点30分，上海谊众下跌7.72%，报44.01元/股，成交1127万元，换手率0.12%，振幅0.02%。消息解读上海谊众4月22日发布了2024年度财报，尽管其核心产品注射用紫杉醇聚合物胶束成功纳入国家医保目录，但受市场准入困难及研发投入增加等因素影响，公司营收与净利润双双大幅下滑。2024年上海谊众实现营业收入1.74亿元，同比下降...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423093415974161b0&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>上海谊众大跌7.72% 营收净利双下滑</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n上海谊众大跌7.72% 营收净利双下滑\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-23 09:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423093415974161b0&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>04月23日，上海谊众（688091）股价大幅下跌，截至09点30分，上海谊众下跌7.72%，报44.01元/股，成交1127万元，换手率0.12%，振幅0.02%。消息解读上海谊众4月22日发布了2024年度财报，尽管其核心产品注射用紫杉醇聚合物胶束成功纳入国家医保目录，但受市场准入困难及研发投入增加等因素影响，公司营收与净利润双双大幅下滑。2024年上海谊众实现营业收入1.74亿元，同比下降...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423093415974161b0&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688091","symbol_name":"上海谊众","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423093415974161b0&s=b","article_id":"2529594789","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423093415974161b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2529594789","pubTimestamp":1745371801,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"消息解读上海谊众4月22日发布了2024年度财报，尽管其核心产品注射用紫杉醇聚合物胶束成功纳入国家医保目录，但受市场准入困难及研发投入增加等因素影响，公司营收与净利润双双大幅下滑。2024年上海谊众实现营业收入1.74亿元，同比下降51.83%；归母净利润为697.53万元，同比下降95.68%。此外，2024年上海谊众研发投入激增，公司研发投入为同比增长65.71%至3720.37万元，较上年增加15.21个百分点。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"688091":"上海谊众"},"translate_title":"Shanghai Yizhong fell 7.72%, both revenue and net profit fell","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688091":1},"content_text":"04月23日，上海谊众（688091）股价大幅下跌，截至09点30分，上海谊众下跌7.72%，报44.01元/股，成交1127万元，换手率0.12%，振幅0.02%。消息解读上海谊众4月22日发布了2024年度财报，尽管其核心产品注射用紫杉醇聚合物胶束成功纳入国家医保目录，但受市场准入困难及研发投入增加等因素影响，公司营收与净利润双双大幅下滑。2024年上海谊众实现营业收入1.74亿元，同比下降51.83%；归母净利润为697.53万元，同比下降95.68%。经营活动产生的现金流量净额为3,943.70万元，同比下降54.44%，主要系报告期内营销投入和研发支出较上年同期增加所致。核心产品注射用紫杉醇聚合物胶束在2024年实现收入1.73亿元，同比下降51.90%，毛利率为92.97%，较上年减少0.79个百分点。该产品销量下降的主要原因在于在医院准入、药房配置与回院输注等环节存在困难，大幅影响了产品的销量。此外，2024年上海谊众研发投入激增，公司研发投入为同比增长65.71%至3720.37万元，较上年增加15.21个百分点。资金动向截止发稿，上海谊众获得主力净流出419万元，其中超大单流出654万元，大单流入235万元。数据显示，该股今日净流入较近5日净流入均值减少334万元。主营业务及业绩上海谊众公司主营业务为抗肿瘤药物改良型新药的研发及产业化。最新财报显示，今年一季报，上海谊众实现营业收入7,103.22万元，同比增长3.39%，净利润为1,418.60万元，同比减少51.38%，基本每股收益为0.07元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2529594789","isCrawlerRequest":true}